Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Otsuka Pharmaceutical Co. Ltd.

Division of Otsuka Holdings Co. Ltd.
www.otsuka.co.jp/en/

Latest From Otsuka Pharmaceutical Co. Ltd.

Astex Eyes First Filing For Oral Decitabine On Positive Combo Results

Otsuka subsidiary Astex plans filing in MDS by year-end for first oral decitabine product on the back of positive Phase III comparative results.

Cancer Clinical Trials

Google's Verily Makes Clinical Trials Pitch With Big Pharma Pacts

Verily has kept a low profile since it was set up in 2015 but deals with Novartis, Otsuka, Pfizer and Sanofi reveal the data management giant's ambitions to become a major player in the lucrative clinical studies space.

Clinical Trials Digital Health

Biotech CEOs: Can Scientist-Founders Remain In Charge?

Founder-CEOs do not typically remain at the helm as biotechs mature. Exceptions to that rule are multiplying, though, especially in Europe as companies aim directly for Nasdaq.

C-Suite Speaks Business Strategies

Vonoprazan Provides Foundation For Newly Minted Phathom

Newly formed US venture Phathom, with industry veteran Tachi Yamada on board, has picked up selected rights to P-CAB molecule as Takeda continues to shed non-core assets and rights.

Gastrointestinal Deals
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register